Skip to content
healthcare.dev
Get a free key

Skyrizi

NDC 0074-2100, risankizumab-rzaa, injection, from AbbVie Inc..

Product NDC
0074-2100
Status
Listed
Labeler
AbbVie Inc.
Dosage form
INJECTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761105
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0074-2100 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RISANKIZUMAB150 mg/mL

Pharmacologic classes

Interleukin-23 Antagonist [EPC]; Interleukin-23 Antagonists [MoA]

Package NDCNDC-11Package
0074-2100-01000742100011 SYRINGE in 1 CARTON (0074-2100-01) / 1 mL in 1 SYRINGE
0074-2100-70000742100701 SYRINGE in 1 CARTON (0074-2100-70) / 1 mL in 1 SYRINGE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7148c8eb-b39e-e20a-6494-a6df82392858

  • NADAC price for package 00074210001

    GET /v1/drugs/nadac/00074210001

Use it

Look up 0074-2100 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0074-2100 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0074-2100. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.